Human CD30/TNFRSF8 F(ab')2 (Research Grade Brentuximab Biosimilar) Antibody, Novus Biologicals™

CD30/TNFRSF8

Flow Cytometry 0.25 ug/mL

Monoclonal

Purified

RUO

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.

943

IgG1

Protein A or G purified from cell culture supernatant

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Hu8F2

Flow Cytometry

Unconjugated

Human

Human

CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8

Human CD30/TNFRSF8

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.